Gabepentinoids and Benzodiazepines in Medicare Part D
- PMID: 30242102
- PMCID: PMC6218855
- DOI: 10.1681/ASN.2018070745
Gabepentinoids and Benzodiazepines in Medicare Part D
Keywords: gabapentin; pharmacoepidemiology; pregabalin.
Comment in
-
Authors' Reply.J Am Soc Nephrol. 2018 Nov;29(11):2771-2772. doi: 10.1681/ASN.2018080811. Epub 2018 Sep 21. J Am Soc Nephrol. 2018. PMID: 30242103 Free PMC article. No abstract available.
Comment on
-
Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients.J Am Soc Nephrol. 2018 Jul;29(7):1970-1978. doi: 10.1681/ASN.2018010096. Epub 2018 Jun 5. J Am Soc Nephrol. 2018. PMID: 29871945 Free PMC article.
References
-
- Chen YC, Kreling DH: The effect of the Medicare Part D benzodiazepine exclusion on the utilization patterns of benzodiazepines and substitute medications. Res Social Adm Pharm 10: 438–447, 2014 - PubMed
-
- Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Réglat A: Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 25: 61–70, 2008 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources